1. Home
  2. IRWD
  3. IRWD News

Latest Ironwood Pharmaceuticals Inc. (IRWD) News on June 2, 2025

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
IRWD

Zacks

25 days ago

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates
IRWD

Zacks

a month ago

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates

IRWD

Associated Press Finance

a month ago

Ironwood: Q1 Earnings Snapshot

Ironwood Pharmaceuticals Reports First Quarter 2025 Results
IRWD

Business Wire

a month ago

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
IRWD

Zacks

a month ago

Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for
IRWD

Zacks

a month ago

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
IRWD

Business Wire

a month ago

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
IRWD

Business Wire

a month ago

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
IRWD

Business Wire

a month ago

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News
IRWD

Zacks

2 months ago

Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News

Ironwood Shares Tank on Regulatory Update for Apraglutide
IRWD

Zacks

2 months ago

Ironwood Shares Tank on Regulatory Update for Apraglutide

IRWD

MT Newswires

2 months ago

Wells Fargo Downgrades Ironwood Pharmaceuticals to Equalweight From Overweight, Adjusts Price Target to $1 From $7

IRWD

MT Newswires

2 months ago

Jefferies Downgrades Ironwood Pharmaceuticals to Hold From Buy, Adjusts Price Target to $0.70 From $8

Ironwood’s shares sink as FDA demands new trial for lead drug
IRWD

Pharmaceutical Technology

2 months ago

Ironwood’s shares sink as FDA demands new trial for lead drug

IRWD

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

IRWD

MT Newswires

2 months ago

Top Midday Decliners

IRWD

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Monday Afternoon

IRWD

MT Newswires

2 months ago

Ironwood Says FDA to Require Additional Phase 3 Trial for Apraglutide; to Explore Strategic Options

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
IRWD

Business Wire

2 months ago

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday?
IRWD

Insider Monkey

2 months ago

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday?

Corcept (CORT) Stock Jumps 109.1%: Will It Continue to Soar?
IRWD

Zacks

2 months ago

Corcept (CORT) Stock Jumps 109.1%: Will It Continue to Soar?

IRWD

MT Newswires

2 months ago

Ironwood Pharmaceuticals Gets Nasdaq Non-Compliance Notice

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
IRWD

Business Wire

2 months ago

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?
IRWD

Zacks

2 months ago

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now?
IRWD

Insider Monkey

3 months ago

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now?

IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down
IRWD

Zacks

3 months ago

IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ...
IRWD

GuruFocus.com

3 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ...

IRWD

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Ironwood Pharmaceuticals Inc Earnings Call

Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates
IRWD

Zacks

3 months ago

Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates

IRWD

Associated Press Finance

3 months ago

Ironwood: Q4 Earnings Snapshot

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
IRWD

Business Wire

3 months ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Report Preview: What To Look For
IRWD

GuruFocus.com

3 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Report Preview: What To Look For

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
IRWD

Business Wire

3 months ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Millrose Properties Set to Join S&P SmallCap 600
IRWD

PR Newswire

4 months ago

Millrose Properties Set to Join S&P SmallCap 600

IRWD

Argus Research

4 months ago

IRWD: Lowering target price to $2.00

IRWD

MT Newswires

4 months ago

Top Midday Decliners

IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls
IRWD

Zacks

4 months ago

IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls

IRWD

MT Newswires

4 months ago

Ironwood Pharmaceuticals to Slash Half of Workforce, Drop Phase 2 Testing of Drug; Issues 2025 Outlook

IRWD

Business Wire

4 months ago

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

IRWD

Argus Research

4 months ago

IRWD: What does Argus have to say about IRWD?

Calculating The Fair Value Of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
IRWD

Simply Wall St.

4 months ago

Calculating The Fair Value Of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

IRWD

Argus Research

4 months ago

IRWD: What does Argus have to say about IRWD?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
IRWD

TipRanks

4 months ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

IRWD

Argus Research

5 months ago

IRWD: Lowering target price to $3.00

IRWD

Argus Research

5 months ago

IRWD: Raising target price to $4.00

Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)
IRWD

Insider Monkey

5 months ago

Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)

IRWD

Argus Research

6 months ago

IRWD: What does Argus have to say about IRWD?

IRWD

Argus Research

6 months ago

IRWD: What does Argus have to say about IRWD?

High Growth Tech Stocks In The United States To Watch
IRWD

Simply Wall St.

6 months ago

High Growth Tech Stocks In The United States To Watch

IRWD

Argus Research

6 months ago

IRWD: What does Argus have to say about IRWD?

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
IRWD

Business Wire

6 months ago

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
IRWD

Business Wire

7 months ago

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

IRWD

Argus Research

7 months ago

IRWD: What does Argus have to say about IRWD?

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down
IRWD

Zacks

7 months ago

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...
IRWD

GuruFocus.com

7 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
IRWD

Zacks

7 months ago

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates

IRWD

Associated Press Finance

7 months ago

Ironwood: Q3 Earnings Snapshot

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
IRWD

Business Wire

7 months ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect
IRWD

GuruFocus.com

7 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect

IRWD

Argus Research

7 months ago

IRWD: Raising target price to $4.00

IRWD

MT Newswires

7 months ago

Ironwood Says Apraglutide Shows 'Consistent Treatment Effect' in Short Bowel Syndrome; Shares Rise

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
IRWD

Business Wire

7 months ago

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
IRWD

Business Wire

7 months ago

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares
IRWD

GuruFocus.com

8 months ago

State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?
IRWD

Insider Monkey

8 months ago

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?

Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ...
IRWD

GuruFocus.com

8 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ...

IRWD

Argus Research

8 months ago

IRWD: What does Argus have to say about IRWD?

Implied Volatility Surging for Ironwood (IRWD) Stock Options
IRWD

Zacks

9 months ago

Implied Volatility Surging for Ironwood (IRWD) Stock Options

IRWD

MT Newswires

9 months ago

Leerink Partners Initiates Coverage on Ironwood Pharmaceuticals With Market Perform Rating, $5 Price Target

Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?
IRWD

Insider Monkey

9 months ago

Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
IRWD

Business Wire

9 months ago

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

IRWD

Argus Research

9 months ago

IRWD: What does Argus have to say about IRWD?

IRWD

Argus Research

9 months ago

IRWD: Raising target price to $4.00

Analysts Have Just Cut Their Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenue Estimates By 13%
IRWD

Simply Wall St.

10 months ago

Analysts Have Just Cut Their Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenue Estimates By 13%

Ironwood Pharmaceuticals, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
IRWD

Simply Wall St.

10 months ago

Ironwood Pharmaceuticals, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
IRWD

Zacks

10 months ago

Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates

Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2
IRWD

Zacks

10 months ago

Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2

IRWD

Associated Press Finance

10 months ago

Ironwood: Q2 Earnings Snapshot

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
IRWD

Business Wire

10 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline
IRWD

Zacks

10 months ago

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline

Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders have endured a 49% loss from investing in the stock three years ago
IRWD

Simply Wall St.

10 months ago

Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders have endured a 49% loss from investing in the stock three years ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
IRWD

Business Wire

10 months ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

IRWD

Argus Research

10 months ago

IRWD: Lowering target price to $5.00

Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options
IRWD

Zacks

a year ago

Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options

IRWD

Argus Research

a year ago

IRWD: Raising target price to $6.00

IRWD

Argus Research

a year ago

IRWD: What does Argus have to say about IRWD?

IRWD

Argus Research

a year ago

IRWD: Lowering target price to $5.00

IRWD

MT Newswires

a year ago

Ironwood Pharmaceuticals Names Sravan Emany to Additional Role of Chief Operating Officer

Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
IRWD

GuruFocus.com

a year ago

Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)

Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ...
IRWD

GuruFocus.com

a year ago

Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ...

IRWD

MT Newswires

a year ago

Ironwood Pharmaceuticals Insider Sold Shares Worth $517,694, According to a Recent SEC Filing

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

IRWD

MT Newswires

a year ago

Ironwood Pharmaceuticals Insider Sold Shares Worth $436,136, According to a Recent SEC Filing

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
IRWD

Business Wire

a year ago

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results
IRWD

Simply Wall St.

a year ago

US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results

IRWD

GuruFocus.com

a year ago

Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
IRWD

Insider Monkey

a year ago

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript

Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
IRWD

Zacks

a year ago

Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates

Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)
IRWD

Simply Wall St.

a year ago

Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)

IRWD

MT Newswires

a year ago

Sector Update: Health Care Stocks Higher Late Afternoon

Share on Social Networks: